<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>16</patient-age><report-id>PHFR2007GB02037</report-id><gender>unknown</gender><reactions><reaction>Cardiorespiratory arrest</reaction><reaction>Pulmonary embolus</reaction><reaction>DVT</reaction><reaction>Pleural effusion</reaction><reaction>Shortness of breath</reaction><reaction>Deterioration of physical condition</reaction><reaction>haemolytic anaemia thought to be auto-immune in origin</reaction><reaction>Red cell count decreased </reaction><reaction>Looked pale</reaction><reaction>Haemolgobin was 6.2 g/dl, 5.5 g/dl</reaction><reaction>Collapsed</reaction><reaction>Abdominal pain</reaction><reaction>Painful urination</reaction><reaction>White blood cell count increased</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>CLOZARIL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TRAZODONE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>VALPROATE SODIUM</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>OLANZAPINE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>LORAZEPAM</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>IBUPROFEN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CLOPIXOL /00876701/</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>AUGMENTIN /UNK/</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>MEBEVERINE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CHLORPROMAZINE</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Post-traumatic stress disorder</indication><indication>Irritable bowel syndrome</indication></indications><outcomes><outcome>Death</outcome><outcome>Life Threatening</outcome><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>United Kingdom</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4053106_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20121211133615</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>PHFR2007GB02037</safetyreportid>
		<primarysourcecountry>GB</primarysourcecountry>
		<occurcountry>GB</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2012-12-11</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>1</seriousnessdeath>
		<seriousnesslifethreatening>1</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2007-06-29</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2012-12-03</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHFR2007GB02037</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<linkedreport>
			<linkreportnumb>PHHY2009GB55164</linkreportnumb>
		</linkedreport>
		<linkedreport>
			<linkreportnumb>PHHY2009GB55164</linkreportnumb>
		</linkedreport>
		<primarysource>
			<reportertitle>Dr</reportertitle>
			<reporterfamilyname>Bronoff</reporterfamilyname>
			<reportercountry>GB</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reportertitle>Dr</reportertitle>
			<reportergivename>Louise</reportergivename>
			<reporterfamilyname>Quinn</reporterfamilyname>
			<reporterorganization>St Andrews Hospital</reporterorganization>
			<reporterstreet>Billing Road</reporterstreet>
			<reportercity>Northampton</reportercity>
			<reporterpostcode>NN1 5DG</reporterpostcode>
			<reportercountry>GB</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>GB</reportercountry>
			<qualification code="2">Pharmacist</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>GB</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>GB</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>JS</patientinitial>
			<patientbirthdateformat>102</patientbirthdateformat>
			<patientbirthdate>19901031</patientbirthdate>
			<patientweight>106</patientweight>
			<patientheight>159</patientheight>
			<patientsex code="2">Female</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Obesity</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Drug hypersensitivity</patientepisodename>
				<patientmedicalcomment>to haloperidol</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Irritable bowel syndrome</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Transfusion</patientepisodename>
			</medicalhistoryepisode>
			<patientpastdrugtherapy>
				<patientdrugname>HALOPERIDOL</patientdrugname>
			</patientpastdrugtherapy>
			<patientdeath>
				<patientdeathdateformat>102</patientdeathdateformat>
				<patientdeathdate>20070819</patientdeathdate>
				<patientautopsyyesno>3</patientautopsyyesno>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Cardio-respiratory arrest</patientdeathreport>
				</patientdeathcause>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Pulmonary embolism</patientdeathreport>
				</patientdeathcause>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Deep vein thrombosis</patientdeathreport>
				</patientdeathcause>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Pleural effusion</patientdeathreport>
				</patientdeathcause>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Dyspnoea</patientdeathreport>
				</patientdeathcause>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>General physical condition</patientdeathreport>
				</patientdeathcause>
			</patientdeath>
			<reaction>
				<primarysourcereaction>Cardiorespiratory arrest</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Cardio-respiratory arrest</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Cardio-respiratory arrest</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070819</reactionstartdate>
				<reactionfirsttime>124</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>48</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Pulmonary embolus</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Pulmonary embolus</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Pulmonary embolism</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>DVT</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>DVT</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Deep vein thrombosis</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Pleural effusion</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Pleural effusion</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Pleural effusion</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Shortness of breath</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Shortness of breath</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Dyspnoea</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070817</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20070819</reactionenddate>
				<reactionduration>3</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>121</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>45</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Deterioration of physical condition</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>General physical condition</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>General physical condition</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070817</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20070819</reactionenddate>
				<reactionduration>3</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>121</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>45</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>haemolytic anaemia thought to be auto-immune in origin</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Autoimmune haemolytic anaemia NOS</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Anaemia haemolytic autoimmune</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070626</reactionstartdate>
				<reactionfirsttime>70</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Red cell count decreased </primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Red blood cell count decreased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Red blood cell count decreased</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Looked pale</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Looked pale</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Pallor</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070622</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20070622</reactionenddate>
				<reactionduration>1</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>65</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Haemolgobin was 6.2 g/dl, 5.5 g/dl</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Hb decreased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Haemoglobin decreased</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070623</reactionstartdate>
				<reactionfirsttime>67</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Collapsed</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Collapse circulatory</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Circulatory collapse</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070622</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20070622</reactionenddate>
				<reactionduration>1</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>66</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Abdominal pain</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Abdominal pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Abdominal pain</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070817</reactionstartdate>
				<reactionfirsttime>122</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>46</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Painful urination</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Painful urination</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Dysuria</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070817</reactionstartdate>
				<reactionfirsttime>122</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>46</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>White blood cell count increased</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>White blood cell count increased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>White blood cell count increased</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070623</testdate>
				<testname>Haematocrit</testname>
				<testresult>17</testresult>
				<testunit>%</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070810</testdate>
				<testname>Haematocrit</testname>
				<testresult>15</testresult>
				<testunit>%</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070817</testdate>
				<testname>Haematocrit</testname>
				<testresult>21</testresult>
				<testunit>%</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070623</testdate>
				<testname>Haemoglobin</testname>
				<testresult>6.2</testresult>
				<testunit>g/dl</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070810</testdate>
				<testname>Haemoglobin</testname>
				<testresult>5.5</testresult>
				<testunit>g/dl</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070817</testdate>
				<testname>Haemoglobin</testname>
				<testresult>5.5</testresult>
				<testunit>g/dl</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070727</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>37.8</testresult>
				<testunit>pg</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070810</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>41.4</testresult>
				<testunit>pg</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070817</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>38.8</testresult>
				<testunit>pg</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070810</testdate>
				<testname>Mean cell volume</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070817</testdate>
				<testname>Mean cell volume</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20080727</testdate>
				<testname>Mean cell volume</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070623</testdate>
				<testname>Red blood cell count</testname>
				<testresult>1.84</testresult>
				<testunit>10^9/L</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070727</testdate>
				<testname>Red blood cell count</testname>
				<testresult>3.18</testresult>
				<testunit>10^9/L</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070810</testdate>
				<testname>Red blood cell count</testname>
				<testresult>1.33</testresult>
				<testunit>10^9/L</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070817</testdate>
				<testname>Red blood cell count</testname>
				<testresult>1.91</testresult>
				<testunit>10^9/L</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20070817</testdate>
				<testname>Reticulocyte count</testname>
				<testresult>190</testresult>
				<testunit>10^9/L</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>CLOZARIL</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationnumb>19-758</drugauthorizationnumb>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>300</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>14350</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>300 mg, QD</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Post-traumatic stress disorder</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2007-04-18</drugstartdate>
				<drugstartperiod>124</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<druglastperiod>48</druglastperiod>
				<druglastperiodunit>804</druglastperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2007-05-12</drugenddate>
				<drugtreatmentduration>24</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CLOZAPINE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Anaemia haemolytic autoimmune</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Anaemia haemolytic autoimmune</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardio-respiratory arrest</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardio-respiratory arrest</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Circulatory collapse</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Circulatory collapse</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Deep vein thrombosis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Deep vein thrombosis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dyspnoea</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dyspnoea</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dysuria</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dysuria</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>General physical condition</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>General physical condition</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Haemoglobin decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Haemoglobin decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pallor</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pallor</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pleural effusion</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pleural effusion</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pulmonary embolism</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pulmonary embolism</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Red blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Red blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count increased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count increased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>CLOZARIL</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationnumb>19-758</drugauthorizationnumb>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>275</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>14350</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>275 mg, QD</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2007-06-07</drugstartdate>
				<drugstartperiod>124</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<druglastperiod>48</druglastperiod>
				<druglastperiodunit>804</druglastperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2007-07-03</drugenddate>
				<drugtreatmentduration>26</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CLOZAPINE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Anaemia haemolytic autoimmune</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Anaemia haemolytic autoimmune</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardio-respiratory arrest</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardio-respiratory arrest</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Circulatory collapse</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Circulatory collapse</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Deep vein thrombosis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Deep vein thrombosis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dyspnoea</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dyspnoea</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dysuria</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dysuria</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>General physical condition</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>General physical condition</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Haemoglobin decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Haemoglobin decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pallor</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pallor</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pleural effusion</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pleural effusion</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pulmonary embolism</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pulmonary embolism</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Red blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Red blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count increased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count increased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>TRAZODONE</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>300</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>300 mg, QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Post-traumatic stress disorder</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2006-12-01</drugstartdate>
				<drugenddateformat>610</drugenddateformat>
				<drugenddate>2007-08-01</drugenddate>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>TRAZODONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>VALPROATE SODIUM</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>1200</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>1200 mg, QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Post-traumatic stress disorder</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2005-12-01</drugstartdate>
				<drugenddateformat>610</drugenddateformat>
				<drugenddate>2007-08-01</drugenddate>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>VALPROATE SODIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>OLANZAPINE</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>20</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>20 mg, QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Post-traumatic stress disorder</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2005-10-01</drugstartdate>
				<drugenddateformat>610</drugenddateformat>
				<drugenddate>2007-08-01</drugenddate>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>OLANZAPINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>LORAZEPAM</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>4</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>4 mg, PRN</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Post-traumatic stress disorder</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2004-10-01</drugstartdate>
				<drugenddateformat>610</drugenddateformat>
				<drugenddate>2007-08-01</drugenddate>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>LORAZEPAM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>IBUPROFEN</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugdosagetext>UNK UKN, PRN</drugdosagetext>
				<drugadministrationroute code="065">Unknown</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>IBUPROFEN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CLOPIXOL /00876701/</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>50</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>50 mg, QD</drugdosagetext>
				<drugadministrationroute code="030">Intramuscular</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Post-traumatic stress disorder</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2007-06-05</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2007-06-05</drugenddate>
				<drugtreatmentduration>1</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ZUCLOPENTHIXOL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CLOPIXOL /00876701/</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>75</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>75 UNK, UNK</drugdosagetext>
				<drugadministrationroute code="030">Intramuscular</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2007-06-20</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2007-06-20</drugenddate>
				<drugtreatmentduration>1</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ZUCLOPENTHIXOL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>AUGMENTIN /UNK/</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugdosagetext>UNK</drugdosagetext>
				<drugadministrationroute code="065">Unknown</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>AMOXICILLIN, CLAVULANATE POTASSIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>MEBEVERINE</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>135</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>3</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>135 mg, TID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Irritable bowel syndrome</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2004-12-01</drugstartdate>
				<drugenddateformat>610</drugenddateformat>
				<drugenddate>2007-08-01</drugenddate>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>MEBEVERINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CHLORPROMAZINE</medicinalproduct>
				<obtaindrugcountry>GB</obtaindrugcountry>
				<drugauthorizationcountry>GB</drugauthorizationcountry>
				<drugstructuredosagenumb>200</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>200 mg, PRN</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Post-traumatic stress disorder</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2004-10-01</drugstartdate>
				<drugenddateformat>610</drugenddateformat>
				<drugenddate>2007-08-01</drugenddate>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CHLORPROMAZINE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical><Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">Initial </Semaphore>solicited <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>registry report combining information received on 29 Jun 2007, 03 Jul 2007 and 04 Jul 2007 from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>and <Semaphore x="2394141" class="Occupation" value="Pharmacist" score="1.00" ID="C51840">pharmacist</Semaphore>: This patient had been receiving <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>(<Semaphore x="385490" class="Medicine" value="Clozapine" score="0.49" ID="252210">clozapine</Semaphore>) as <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore>for <Semaphore x="2499616" class="Disease or Finding" value="Schizophrenia" score="1.00" ID="C3362">schizophrenia </Semaphore>since 29 May 2007. In 00 Jun 2007 <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">ca</Semaphore>. 2-3 weeks later the patient was hospitalized following a <Semaphore x="1791688" class="Disease or Finding" value="Collapse" score="1.00" ID="C50497">collapse </Semaphore>where she was <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>with <Semaphore x="2015326" class="Disease or Finding" value="Hemolytic Anemia" score="1.00" ID="C34376">haemolytic anaemia </Semaphore>thought to be auto immune in origin. The patient's Hb was around 5 (no units) but following a <Semaphore x="1607470" class="Procedure" value="Blood Transfusion" score="1.00" ID="C15192">blood transfusion </Semaphore>this rose to 8.5. The patient was prescribed <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore>with <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="0.49" ID="291320">prednisolone</Semaphore>, <Semaphore x="173389" class="Medicine" value="Augmentin" score="0.49" ID="239493">Augmentin</Semaphore>, <Semaphore x="596508" class="Medicine" value="Folic Acid" score="0.49" ID="268863">folic acid </Semaphore>and Clexane. The patient also developed a <Semaphore x="3321028" class="MedDRA LLT" value="White blood cell count increased" score="1.00" ID="10047943">high <Semaphore x="3321117" class="MedDRA LLT" value="White blood cell count" score="1.00" ID="10047939"><Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">white <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">blood cell </Semaphore></Semaphore>
      <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">
       <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
        </Semaphore></Semaphore></Semaphore>
     <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">
      <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
       <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">count </Semaphore></Semaphore></Semaphore>
     <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
      </Semaphore></Semaphore>of 24.5x10^9/l. <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore>was discontinued due to <Semaphore x="1524787" class="Disease or Finding" value="Anemia" score="1.00" ID="C2869">anaemia</Semaphore>. No reporter causality or patient <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>were provided. In the absence of information from a healthcare <Semaphore x="2425040" class="Occupation" value="Professional Occupation" score="1.00" ID="C75558">professional </Semaphore>the sponsor's medical safety expert has provisionally assessed the elevated <Semaphore x="3321117" class="MedDRA LLT" value="White blood cell count" score="1.00" ID="10047939"><Semaphore x="3321117" class="MedDRA LLT" value="White blood cell count" score="1.00" ID="10047939"><Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">white <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">blood cell </Semaphore></Semaphore>
      <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">
       <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
        </Semaphore></Semaphore></Semaphore>
     <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">
      <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
       <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">count </Semaphore></Semaphore></Semaphore>
     <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">
      </Semaphore></Semaphore>as suspected and the <Semaphore x="2015326" class="Disease or Finding" value="Hemolytic Anemia" score="1.00" ID="C34376">haemolytic anaemia </Semaphore>as not suspected to be related to <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">therapy</Semaphore>, <Semaphore x="1675087" class="Disease or Finding" value="Cant" score="1.00" ID="C82117">based </Semaphore>on available information.Follow up solicited <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>registry report received from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 22 Nov 2007: This patient who had a history of <Semaphore x="2328461" class="Disease or Finding" value="Obesity" score="1.00" ID="C3283">obesity</Semaphore>, <Semaphore x="2050824" class="Disease or Finding" value="Increased Sputum Excretion" score="1.00" ID="C35638">sensitivity </Semaphore>to <Semaphore x="652738" class="Medicine" value="Haloperidol" score="0.49" ID="269889">haloperidol </Semaphore>and <Semaphore x="2080803" class="Disease or Finding" value="Irritable Bowel Syndrome" score="1.00" ID="C82343">irritable bowel syndrome</Semaphore>, received <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore>with <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>for complex <Semaphore x="2414605" class="Disease or Finding" value="Post Abortion Hemorrhage" score="1.00" ID="C35617">PTSD </Semaphore>(<Semaphore x="2415194" class="Disease or Finding" value="Post-Traumatic Stress Disorder" score="1.00" ID="C3389">post traumatic stress disorder</Semaphore>) and not <Semaphore x="2499616" class="Disease or Finding" value="Schizophrenia" score="1.00" ID="C3362">schizophrenia </Semaphore>as previously stated. On 03 Jul 2007, about 11 weeks after first starting <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment</Semaphore>, <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>was <Semaphore x="2588752" class="Procedure" value="Study of High Risk Factors" score="1.00" ID="C62697">withdrawn </Semaphore>following development of <Semaphore x="2367012" class="Disease or Finding" value="Pallor" score="1.00" ID="C50685">pallor </Semaphore>and <Semaphore x="1557856" class="Disease or Finding" value="Autoimmune Hemolytic Anemia" score="1.00" ID="C34378">autoimmune <Semaphore x="2987645" class="MedDRA LLT" value="Haemolytic anaemia" score="1.00" ID="10018916">haemolytic anaemia</Semaphore></Semaphore>. No antibodies were found on <Semaphore x="3049513" class="MedDRA LLT" value="Investigation" score="1.00" ID="10062026">investigation </Semaphore>of the <Semaphore x="1524787" class="Disease or Finding" value="Anemia" score="1.00" ID="C2869">anaemia</Semaphore>. The patient showed substantial improvement following <Semaphore x="2699974" class="Disease or Finding" value="Withdrawal" score="1.00" ID="C41341">withdrawal </Semaphore>of <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril</Semaphore>. She also received <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">treatment </Semaphore>with <Semaphore x="949575" class="Medicine" value="Omeprazole" score="0.49" ID="273990">omeprazole </Semaphore>and co trimoxazole for unknown indications. The <Semaphore x="2014691" class="Disease or Finding" value="Hemoglobin Decreased" score="1.00" ID="C80085">haemoglobin decreased </Semaphore>again to about 5.5 (no units) on 10 Aug 2007 but improved <Semaphore x="2529737" class="Procedure" value="Slight Chance of Dozing" score="1.00" ID="C106647">slightly </Semaphore>with <Semaphore x="1607470" class="Procedure" value="Blood Transfusion" score="1.00" ID="C15192">blood transfusion </Semaphore>to 7.4 on 17 Aug 2007. On 17 Aug 2007 the patient developed <Semaphore x="1405770" class="Disease or Finding" value="Abdominal Pain" score="1.00" ID="C26682"><Semaphore x="2706839" class="MedDRA LLT" value="Abdominal pain" score="1.00" ID="10000081"><Semaphore x="1405770" class="Disease or Finding" value="Abdominal Pain" score="1.00" ID="C26682">abdominal <Semaphore x="2919014" class="MedDRA LLT" value="Dysuria" score="1.00" ID="10013990">pain</Semaphore></Semaphore>
      </Semaphore>
     <Semaphore x="2919014" class="MedDRA LLT" value="Dysuria" score="1.00" ID="10013990">, </Semaphore></Semaphore>
    <Semaphore x="2919014" class="MedDRA LLT" value="Dysuria" score="1.00" ID="10013990">painful urination</Semaphore>, <Semaphore x="1870759" class="Disease or Finding" value="Dyspnea" score="1.00" ID="C2998">shortness of breath </Semaphore>and a <Semaphore x="2407275" class="Disease or Finding" value="Pleural Effusion" score="1.00" ID="C3331">pleural effusion</Semaphore>. Her <Semaphore x="2397639" class="Procedure" value="Physical Examination" score="1.00" ID="C20989">physical </Semaphore>condition deteriorated and two days later, on 19 Aug 2007, she died following a <Semaphore x="2842969" class="MedDRA LLT" value="Cardio-respiratory arrest" score="1.00" ID="10007617">cardiorespiratory arrest</Semaphore>. A post mortem examination showed <Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">DVT </Semaphore>(<Semaphore x="2896219" class="MedDRA LLT" value="Deep vein thrombosis" score="1.00" ID="10051055"><Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">deep <Semaphore x="3215141" class="MedDRA LLT" value="Pulmonary venous thrombosis" score="1.00" ID="10037459">venous <Semaphore x="3214620" class="MedDRA LLT" value="Pulmonary thrombosis" score="1.00" ID="10037437">thrombosis</Semaphore></Semaphore></Semaphore>
     <Semaphore x="3215141" class="MedDRA LLT" value="Pulmonary venous thrombosis" score="1.00" ID="10037459">
      </Semaphore></Semaphore>
    <Semaphore x="3215141" class="MedDRA LLT" value="Pulmonary venous thrombosis" score="1.00" ID="10037459">
     <Semaphore x="3214620" class="MedDRA LLT" value="Pulmonary thrombosis" score="1.00" ID="10037437">) and <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">pulmonary </Semaphore></Semaphore>
     <Semaphore x="3213521" class="MedDRA LLT" value="Pulmonary embolism" score="1.00" ID="10037377">
      </Semaphore></Semaphore>
    <Semaphore x="3213521" class="MedDRA LLT" value="Pulmonary embolism" score="1.00" ID="10037377">
     <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">embolism</Semaphore></Semaphore>. Causality with respect to <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>was reported as suspected for <Semaphore x="2367012" class="Disease or Finding" value="Pallor" score="1.00" ID="C50685">pallor</Semaphore>, <Semaphore x="1791688" class="Disease or Finding" value="Collapse" score="1.00" ID="C50497">collapse </Semaphore>and <Semaphore x="1557856" class="Disease or Finding" value="Autoimmune Hemolytic Anemia" score="1.00" ID="C34378">autoimmune <Semaphore x="2987645" class="MedDRA LLT" value="Haemolytic anaemia" score="1.00" ID="10018916">haemolytic anaemia </Semaphore></Semaphore>and possibly not suspected for <Semaphore x="1405770" class="Disease or Finding" value="Abdominal Pain" score="1.00" ID="C26682"><Semaphore x="2706839" class="MedDRA LLT" value="Abdominal pain" score="1.00" ID="10000081"><Semaphore x="1405770" class="Disease or Finding" value="Abdominal Pain" score="1.00" ID="C26682">abdominal <Semaphore x="2919014" class="MedDRA LLT" value="Dysuria" score="1.00" ID="10013990">pain</Semaphore></Semaphore>
      </Semaphore>
     <Semaphore x="2919014" class="MedDRA LLT" value="Dysuria" score="1.00" ID="10013990">, </Semaphore></Semaphore>
    <Semaphore x="2919014" class="MedDRA LLT" value="Dysuria" score="1.00" ID="10013990">painful urination </Semaphore>and <Semaphore x="1870759" class="Disease or Finding" value="Dyspnea" score="1.00" ID="C2998">shortness of breath</Semaphore>. Causality was not reported for the events of <Semaphore x="3190461" class="MedDRA LLT" value="Pleural effusion" score="1.00" ID="10035598"><Semaphore x="2407275" class="Disease or Finding" value="Pleural Effusion" score="1.00" ID="C3331">pleural <Semaphore x="3190461" class="MedDRA LLT" value="Pleural effusion" score="1.00" ID="10035598">effusion</Semaphore></Semaphore>
      <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">, </Semaphore></Semaphore>
    <Semaphore x="3190461" class="MedDRA LLT" value="Pleural effusion" score="1.00" ID="10035598">
     <Semaphore x="2438634" class="Disease or Finding" value="Pulmonary Fibrosis" score="1.00" ID="C26869">
      <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713"><Semaphore x="2842969" class="MedDRA LLT" value="Cardio-respiratory arrest" score="1.00" ID="10007617">cardiorespiratory <Semaphore x="2463617" class="Disease or Finding" value="Respiratory Arrest" score="1.00" ID="C101772">arrest</Semaphore></Semaphore>
       <Semaphore x="3229081" class="MedDRA LLT" value="Respiratory arrest" score="1.00" ID="10038669">
        <Semaphore x="2463650" class="AnatomicStructure" value="Respiratory Bronchiole" score="1.00" ID="C33465">
         <Semaphore x="2463635" class="AnatomicStructure" value="Respiratory Bronchiole Epithelium" score="1.00" ID="C48943">
          <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">, <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">pulmonary </Semaphore></Semaphore>
          <Semaphore x="2438634" class="Disease or Finding" value="Pulmonary Fibrosis" score="1.00" ID="C26869">
           <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">
            <Semaphore x="3213521" class="MedDRA LLT" value="Pulmonary embolism" score="1.00" ID="10037377">
             </Semaphore></Semaphore></Semaphore></Semaphore>
         <Semaphore x="2438634" class="Disease or Finding" value="Pulmonary Fibrosis" score="1.00" ID="C26869">
          <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">
           <Semaphore x="3213521" class="MedDRA LLT" value="Pulmonary embolism" score="1.00" ID="10037377">
            </Semaphore></Semaphore></Semaphore></Semaphore>
        <Semaphore x="2438634" class="Disease or Finding" value="Pulmonary Fibrosis" score="1.00" ID="C26869">
         <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">
          <Semaphore x="3213521" class="MedDRA LLT" value="Pulmonary embolism" score="1.00" ID="10037377">
           </Semaphore></Semaphore></Semaphore></Semaphore>
       <Semaphore x="2438634" class="Disease or Finding" value="Pulmonary Fibrosis" score="1.00" ID="C26869">
        <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">
         <Semaphore x="3213521" class="MedDRA LLT" value="Pulmonary embolism" score="1.00" ID="10037377">
          </Semaphore></Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>
    <Semaphore x="2438634" class="Disease or Finding" value="Pulmonary Fibrosis" score="1.00" ID="C26869">
     <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">
      <Semaphore x="2438634" class="Disease or Finding" value="Pulmonary Fibrosis" score="1.00" ID="C26869">
       <Semaphore x="2438586" class="Disease or Finding" value="Pulmonary Embolism" score="1.00" ID="C50713">
        <Semaphore x="3213521" class="MedDRA LLT" value="Pulmonary embolism" score="1.00" ID="10037377">
         <Semaphore x="2684714" class="Disease or Finding" value="Venous Embolism" score="1.00" ID="C111654">embolism </Semaphore>
         <Semaphore x="2926810" class="MedDRA LLT" value="Embolism venous" score="1.00" ID="10014522">
          </Semaphore></Semaphore>
        <Semaphore x="2926810" class="MedDRA LLT" value="Embolism venous" score="1.00" ID="10014522">
         </Semaphore></Semaphore>
       <Semaphore x="2926810" class="MedDRA LLT" value="Embolism venous" score="1.00" ID="10014522">
        </Semaphore></Semaphore>
      <Semaphore x="2926810" class="MedDRA LLT" value="Embolism venous" score="1.00" ID="10014522">
       </Semaphore></Semaphore>
     <Semaphore x="2926810" class="MedDRA LLT" value="Embolism venous" score="1.00" ID="10014522">
      </Semaphore></Semaphore>
    <Semaphore x="2926810" class="MedDRA LLT" value="Embolism venous" score="1.00" ID="10014522">
     <Semaphore x="2684714" class="Disease or Finding" value="Venous Embolism" score="1.00" ID="C111654">and <Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">deep <Semaphore x="3311054" class="MedDRA LLT" value="Venous thrombosis" score="1.00" ID="10047249">venous </Semaphore></Semaphore></Semaphore>
     <Semaphore x="2896219" class="MedDRA LLT" value="Deep vein thrombosis" score="1.00" ID="10051055">
      <Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">
       </Semaphore></Semaphore></Semaphore>
    <Semaphore x="2896219" class="MedDRA LLT" value="Deep vein thrombosis" score="1.00" ID="10051055">
     <Semaphore x="1838951" class="Disease or Finding" value="Deep Vein Thrombosis" score="1.00" ID="C49343">
      <Semaphore x="3311054" class="MedDRA LLT" value="Venous thrombosis" score="1.00" ID="10047249">thrombosis</Semaphore></Semaphore></Semaphore>, however the Novartis Medical Safety <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">Physician </Semaphore>has provisionally assessed these events as suspected to be related to <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril</Semaphore>, <Semaphore x="1675087" class="Disease or Finding" value="Cant" score="1.00" ID="C82117">based </Semaphore>on the available information.Following an internal review done on 03 Dec 2012 it was observed that case PHFR2007GB02037 was duplicate of PHHY2009GB55164. So all information from case PHHY2009GB55164 was merged into the case PHFR2007GB02037 and case number PHHY2009GB55164 was deactivated: On 23 Jun 2007, the patient's haematocrift value was 17%, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">haemoglobin </Semaphore>was 6.2 g/dl, <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133"><Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946"><Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">red <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">blood cell </Semaphore></Semaphore>
          </Semaphore>
         <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">count </Semaphore></Semaphore>was 1.84 x 10^9/L. On 27 Jul 2007, patient's <Semaphore x="3100523" class="MedDRA LLT" value="Mean cell haemoglobin" score="1.00" ID="10026989">mean cell <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">haemoglobin </Semaphore></Semaphore>was 37.8 pg, <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133"><Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946"><Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">red <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">blood cell </Semaphore></Semaphore>
          </Semaphore>
         <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">count </Semaphore></Semaphore>was 3.18 x 10^9/l. On 10 Aug 2007, the patient's haematocrift value was 21%, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">haemoglobin </Semaphore>was 5.5 g/dl, <Semaphore x="3100523" class="MedDRA LLT" value="Mean cell haemoglobin" score="1.00" ID="10026989">mean cell <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">haemoglobin </Semaphore></Semaphore>was 41.1 pg, <Semaphore x="3100683" class="MedDRA LLT" value="Mean cell volume" score="1.00" ID="10026999">mean cell volume </Semaphore>was 114 fl and <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133"><Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946"><Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">red <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">blood cell </Semaphore></Semaphore>
          </Semaphore>
         <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">count </Semaphore></Semaphore>was 1.33 x 10^9/l. On 17 Aug 2007, the patient's haematocrift value was 21 %, <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">haemoglobin </Semaphore>was 5.5 g/dl, <Semaphore x="3100523" class="MedDRA LLT" value="Mean cell haemoglobin" score="1.00" ID="10026989">mean cell <Semaphore x="2013340" class="Procedure" value="Hematology Test" score="0.58" ID="C49286">haemoglobin </Semaphore></Semaphore>was 38.8 pg, <Semaphore x="3100683" class="MedDRA LLT" value="Mean cell volume" score="1.00" ID="10026999">mean cell volume </Semaphore>was 111 fl, <Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133"><Semaphore x="1896169" class="Procedure" value="Erythrocyte Count" score="1.00" ID="C51946"><Semaphore x="1606939" class="Procedure" value="Blood Cell Count" score="1.00" ID="C28133">red <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">blood cell </Semaphore></Semaphore>
          </Semaphore>
         <Semaphore x="2803177" class="MedDRA LLT" value="Blood count" score="1.00" ID="10064196">count </Semaphore></Semaphore>was 1.91 x 10^9/l and reticulocyte was 190 x 10^9/L. The event <Semaphore x="1607470" class="Procedure" value="Blood Transfusion" score="1.00" ID="C15192">blood transfusion </Semaphore>was deleted and added as <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">procedure</Semaphore>. The seriousness of the event <Semaphore x="2015326" class="Disease or Finding" value="Hemolytic Anemia" score="1.00" ID="C34376">haemolytic anaemia </Semaphore>thought to be auto immune in origin and <Semaphore x="3168281" class="MedDRA LLT" value="Pallor" score="1.00" ID="10033546">looked pale </Semaphore>was life threatening.</narrativeincludeclinical>
				<sendercomment>Serious adverse event report; cardiorespiratory arrest, deep venous thrombosis, pulmonary embolism (death), assessed as unlisted according to the Core Data Sheet.
It is Novartis' policy to assess a case with a fatal outcome as unlisted unless the label specifically mentions death as a possible outcome of the listed risks.  In the absence of a reporting healthcare professional causality the sponsor's medical safety expert has provisionally assessed the event as suspected, based on currently available information.

Serious adverse event report, autoimmune haemolytic anaemia (involving inpatient hospitalisation), assessed as unlisted according to the Core Data Sheet due to greater severity.
The following term (anaemia) is already included in the Core Data Sheet.  Reporting healthcare professional causality is suspected.

Serious adverse event report, increased white blood cell count (involving inpatient hospitalisation), assessed as listed according to the Core Data Sheet.  In the absence of a reporting healthcare professional causality the sponsor's medical safety expert has provisionally assessed the event as suspected, based on currently available information.

Occurrence of the events within 3 months of the onset of the study drug suggests there is a reasonable possibility of causal relationship for the events cardiorespiratory arrest, pulmonary embolism and DVT. The rest of the events are unassessable.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>